3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
11
Carcinoma, Hepatocellular
7
Colorectal Neoplasms
5
Neoplasm Metastasis
4
Esophageal Squamous Cell Carcinoma
4
Advanced Solid Tumor
4
Solid Tumor
3
Small Cell Lung Carcinoma
3
Esophageal Neoplasms
3
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Recurrence
2
Melanoma
2
Lung Neoplasms
2
Cholangiocarcinoma
2
Carcinoma, Transitional Cell
2
Advanced Solid Tumour
2
Unresectable Stage III Non-small Cell Lung Cancer
1
Triple Negative Breast Neoplasms
1
Skin Neoplasms
1
Simpson-Golabi-Behmel syndrome
1
Rectal Neoplasms
1
Patients With Initially Unresectable MSS-type Advanced Colorectal Cancer With Liver and/or Lung and Peritoneal Metastasis
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Neoplasms
1
Neoplasms
1
Neoplasm, Residual
1
Nasopharyngeal Carcinoma
1
Metastatic Solid Tumors
1
MSI-H/dMMR Solid Tumors
1
Interventions
Fulvestrant
63
Letrozole
53
Paclitaxel
49
Trastuzumab
41
pembrolizumab
40
ribociclib
37
Specimen Handling
37
palbociclib
36
Capecitabine
34
Carboplatin
33
Anastrozole
33
Tamoxifen
32
exemestane
29
pertuzumab
28
abemaciclib
28
Magnetic Resonance Spectroscopy
26
Cyclophosphamide
26
trastuzumab deruxtecan
24
Surveys and Questionnaires
21
Radiotherapy
18
Biopsy
18
olaparib
17
Standard of Care
16
Docetaxel
16
Blood Specimen Collection
16
Taxes
14
Mastectomy, Segmental
14
eribulin
13
elacestrant
13
130-nm albumin-bound paclitaxel
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
tislelizumab
×
90 days
×
Clear all
No trials found.